Anybody here took this one?
Lead Manager is Euroz
Looks like a strong team: https://www.firebrickpharma.com/about/#ourteam
Raising up to $7,000,000 at $0.20. The Enterprise Value at IPO will be $23m.
Firebrick is an Australian pharmaceutical company with a patented product, Nasodine, that is aiming to be the first approved nasal spray medicine targeting the virus that is the cause of the common cold.
Firebrick has completed Phase 1, 2 and 3 trials and is planning a second phase 3 trial starting in 2022.
They are also planning a Phase 2 trial designed to assess Nasodine as a potential treatment for Covid positive patients.
- Forums
- IPOs
- Firebrick Pharma IPO (COVID & common cold nasal spray)
Firebrick Pharma IPO (COVID & common cold nasal spray)
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online